Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00796783 · ClinicalTrials.gov registry record
A Study to Confirm Recurrent or Persistent Cushing's Syndrome in Patients With Signs or Symptoms of Hypercortisolemia
A clinical trial, sponsored by Corcept Therapeutics.
- Terminated
- Registry status
- 2
- Enrollment target
NCT00796783: Clinical Trial study, sponsored by Corcept Therapeutics.
NCT00796783 is a clinical trial that was terminated before completion, run by Corcept Therapeutics. The registered enrollment target is 2 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00796783 was terminated before completion, sponsored by Corcept Therapeutics.
- TERMINATED
- Registry status
- 2 participants
- Enrollment target
Study Summary
This is an observational study to confirm the presence of recurrent or persistent endogenous Cushing's syndrome in patients who have had primary surgical and/or radiation therapy for Cushing's disease and continue to manifest symptoms and signs of hypercortisolemia.
Interventions
- DRUG Cushing's syndrome confirmation
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2 participants |
| Start Date | 2009-02 |
Why NCT00796783 stopped before completion
NCT00796783 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 2 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which Cushing's syndrome confirmation is the first listed.
NCT00796783 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00796783 about?
NCT00796783 is a clinical study titled "A Study to Confirm Recurrent or Persistent Cushing's Syndrome in Patients With Signs or Symptoms of Hypercortisolemia". This is an observational study to confirm the presence of recurrent or persistent endogenous Cushing's syndrome in patients who have had primary surgical and/or radiation therapy for Cushing's disease and continue to manifest symptoms and signs of hypercortisolemia.
What is the current status of trial NCT00796783?
This trial is currently terminated. The enrollment target is 2 participants. The study started on 2009-02.
What interventions are being tested in trial NCT00796783?
The interventions under investigation include: Cushing's syndrome confirmation (DRUG).
Who is sponsoring clinical trial NCT00796783?
This trial is sponsored by Corcept Therapeutics, which has 54 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia